Pharma’s ‘Middleman’ Message Still Resonates With Trump

Some pharma industry CEOs appear to have done well in their meeting with President-elect Donald Trump and his health care team.

President-elect Donald Trump speaks from his Mar-a-Lago club.
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from Elections

More from Vaccines